MeVC22 (R), n=2 cell(s)

Main group: Visual Centrifugal Neurons; Neurotransmitter consensus prediction: Glu

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - - - 43.0 788.0 70.5 0.5 - - 902
1 - - - - 69.5 957.0 63.5 - - - 1090
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - 6.0 248.0 254.0
Pre - - - - - 1.0 31.5 32.5
  AME
0 222.5
1 34.5
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 92
1 9

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:1804
Number of pre synapses:2180
Number of output connections:7288
Coverage factor:1.2
Columnar completeness:0.74
Area completeness:0.95
Cell size (columns):408

Lobula

Number of post synapses:508
Number of pre synapses:65
Number of output connections:149
Coverage factor:1.3
Columnar completeness:0.18
Area completeness:0.54
Cell size (columns):98

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVC22 (R) % % cumu.
0 Cm9 (R) Glu 476 238.0 15.0% 15.0%
1 MeVP14 (R) ACh 266 133.0 8.4% 23.4%
2 Tm30 (R) GABA 239 119.5 7.5% 31.0%
3 MeVPaMe1 (L) ACh 222 111.0 7.0% 38.0%
4 Mi16 (R) GABA 151 75.5 4.8% 42.8%
5 DN1a (R) unclear 143 71.5 4.5% 47.3%
6 Tm5c (R) Glu 137 68.5 4.3% 51.6%
7 LoVP96 (R) Glu 133 66.5 4.2% 55.8%
8 MeVPaMe1 (R) ACh 100 50.0 3.2% 59.0%
9 MeVPaMe2 (L) Glu 98 49.0 3.1% 62.0%
10 Cm31b (R) GABA 91 45.5 2.9% 64.9%
11 MeVP32 (R) ACh 75 37.5 2.4% 67.3%
12 MeLo1 (R) ACh 67 33.5 2.1% 69.4%
13 TmY10 (R) ACh 66 33.0 2.1% 71.5%
14 aMe17b (R) GABA 41 20.5 1.3% 72.8%
15 Cm31a (R) GABA 38 19.0 1.2% 74.0%
16 aMe1 (R) GABA 35 17.5 1.1% 75.1%
17 Mi10 (R) ACh 30 15.0 0.9% 76.0%
18 Mi15 (R) ACh 30 15.0 0.9% 77.0%
19 Dm2 (R) ACh 28 14.0 0.9% 77.9%
20 Cm22 (R) GABA 27 13.5 0.9% 78.7%
21 Tm37 (R) Glu 18 9.0 0.6% 79.3%
22 aMe8 (R) ACh 17 8.5 0.5% 79.8%
23 Cm10 (R) GABA 17 8.5 0.5% 80.4%
24 MeVPMe11 (L) Glu 17 8.5 0.5% 80.9%
25 DNpe053 (L) ACh 16 8.0 0.5% 81.4%
26 MeVPLo2 (R) ACh 16 8.0 0.5% 81.9%
27 MeLo3b (R) ACh 15 7.5 0.5% 82.4%
28 MeVC22 (R) Glu 15 7.5 0.5% 82.9%
29 MeVP29 (R) ACh 15 7.5 0.5% 83.3%
30 aMe5 (R) ACh 13 6.5 0.4% 83.7%
31 aMe2 (R) Glu 12 6.0 0.4% 84.1%
32 Cm3 (R) GABA 12 6.0 0.4% 84.5%
33 MeLo6 (R) ACh 12 6.0 0.4% 84.9%
34 MeVP2 (R) ACh 12 6.0 0.4% 85.3%
35 Cm14 (R) GABA 11 5.5 0.3% 85.6%
36 DNpe053 (R) ACh 11 5.5 0.3% 85.9%
37 Dm8b (R) Glu 10 5.0 0.3% 86.3%
38 LT43 (R) GABA 10 5.0 0.3% 86.6%
39 MeTu3c (R) ACh 10 5.0 0.3% 86.9%
40 MeTu4d (R) ACh 10 5.0 0.3% 87.2%
41 aMe17a (R) Glu 9 4.5 0.3% 87.5%
42 Cm11c (R) ACh 9 4.5 0.3% 87.8%
43 Cm23 (R) Glu 9 4.5 0.3% 88.1%
44 Cm5 (R) GABA 9 4.5 0.3% 88.3%
45 Tm5a (R) ACh 9 4.5 0.3% 88.6%
46 Cm11a (R) ACh 8 4.0 0.3% 88.9%
47 Cm25 (R) Glu 8 4.0 0.3% 89.1%
48 MeVP11 (R) ACh 8 4.0 0.3% 89.4%
49 Tm39 (R) ACh 8 4.0 0.3% 89.6%
50 5thsLNv_LNd6 (R) ACh 7 3.5 0.2% 89.9%
51 aMe4 (R) ACh 7 3.5 0.2% 90.1%
52 Cm1 (R) ACh 7 3.5 0.2% 90.3%
53 Cm29 (R) GABA 7 3.5 0.2% 90.5%
54 LoVC20 (L) GABA 7 3.5 0.2% 90.7%
55 MeVC21 (R) Glu 7 3.5 0.2% 91.0%
56 TmY5a (R) Glu 7 3.5 0.2% 91.2%
57 Cm11d (R) ACh 6 3.0 0.2% 91.4%
58 MeTu3b (R) ACh 6 3.0 0.2% 91.6%
59 MeVP9 (R) ACh 6 3.0 0.2% 91.8%
60 MeVPLo2 (L) ACh 6 3.0 0.2% 91.9%
61 OA-AL2i4 (R) OA 6 3.0 0.2% 92.1%
62 aMe9 (R) ACh 5 2.5 0.2% 92.3%
63 CL063 (R) unclear 5 2.5 0.2% 92.5%
64 Cm8 (R) GABA 5 2.5 0.2% 92.6%
65 Dm8a (R) Glu 5 2.5 0.2% 92.8%
66 Lat2 (R) unclear 5 2.5 0.2% 92.9%
67 LC14b (L) ACh 5 2.5 0.2% 93.1%
68 LC37 (R) Glu 5 2.5 0.2% 93.2%
69 MeLo7 (R) ACh 5 2.5 0.2% 93.4%
70 MeVPMe7 (L) Glu 5 2.5 0.2% 93.6%
71 Tm5b (R) ACh 5 2.5 0.2% 93.7%
72 aMe9 (L) ACh 4 2.0 0.1% 93.8%
73 Cm17 (R) GABA 4 2.0 0.1% 94.0%
74 Cm21 (R) GABA 4 2.0 0.1% 94.1%
75 LoVC22 (L) Dop 4 2.0 0.1% 94.2%
76 MeTu1 (R) ACh 4 2.0 0.1% 94.3%
77 MeTu4f (R) ACh 4 2.0 0.1% 94.5%
78 MeVC20 (R) Glu 4 2.0 0.1% 94.6%
79 MeVP10 (R) ACh 4 2.0 0.1% 94.7%
80 Tm16 (R) ACh 4 2.0 0.1% 94.9%
81 Tm40 (R) ACh 4 2.0 0.1% 95.0%
82 aMe12 (R) ACh 3 1.5 0.1% 95.1%
83 aMe17e (R) Glu 3 1.5 0.1% 95.2%
84 Cm19 (R) GABA 3 1.5 0.1% 95.3%
85 Cm2 (R) ACh 3 1.5 0.1% 95.4%
86 DNp27 (R) unclear 3 1.5 0.1% 95.5%
87 LC14a-2 (L) ACh 3 1.5 0.1% 95.5%
88 Li34a (R) GABA 3 1.5 0.1% 95.6%
89 Li39 (L) GABA 3 1.5 0.1% 95.7%
90 LOLP1 (R) GABA 3 1.5 0.1% 95.8%
91 LoVC23 (L) GABA 3 1.5 0.1% 95.9%
92 LT88 (R) Glu 3 1.5 0.1% 96.0%
93 MeVPMe9 (L) Glu 3 1.5 0.1% 96.1%
94 OA-AL2i3 (R) OA 3 1.5 0.1% 96.2%
95 5-HTPMPV01 (L) unclear 2 1.0 0.1% 96.3%
96 5-HTPMPV03 (R) 5HT 2 1.0 0.1% 96.3%
97 aMe12 (L) ACh 2 1.0 0.1% 96.4%
98 aMe17c (R) Glu 2 1.0 0.1% 96.5%
99 aMe30 (R) Glu 2 1.0 0.1% 96.5%
100 aMe6b (R) ACh 2 1.0 0.1% 96.6%
101 Cm11b (R) ACh 2 1.0 0.1% 96.7%
102 Cm15 (R) GABA 2 1.0 0.1% 96.7%
103 Cm32 (R) GABA 2 1.0 0.1% 96.8%
104 Cm4 (R) Glu 2 1.0 0.1% 96.8%
105 Cm6 (R) GABA 2 1.0 0.1% 96.9%
106 Dm13 (R) GABA 2 1.0 0.1% 97.0%
107 DNc01 (L) unclear 2 1.0 0.1% 97.0%
108 DNc02 (L) unclear 2 1.0 0.1% 97.1%
109 l-LNv (R) unclear 2 1.0 0.1% 97.2%
110 Li14 (R) Glu 2 1.0 0.1% 97.2%
111 LoVCLo2 (L) unclear 2 1.0 0.1% 97.3%
112 LPT51 (R) Glu 2 1.0 0.1% 97.3%
113 MeTu4a (R) ACh 2 1.0 0.1% 97.4%
114 MeVP5 (R) unclear 2 1.0 0.1% 97.5%
115 MeVPMe13 (L) ACh 2 1.0 0.1% 97.5%
116 OLVC2 (L) GABA 2 1.0 0.1% 97.6%
117 OLVC4 (L) unclear 2 1.0 0.1% 97.7%
118 PLP211 (R) unclear 2 1.0 0.1% 97.7%
119 Tm26 (R) ACh 2 1.0 0.1% 97.8%

Outputs

  instance NT total connections connections /#MeVC22 (R) % % cumu.
0 Dm8b (R) Glu 1,546 773.0 19.9% 19.9%
1 Cm11b (R) ACh 1,255 627.5 16.1% 36.0%
2 Cm11d (R) ACh 901 450.5 11.6% 47.6%
3 Cm11a (R) ACh 597 298.5 7.7% 55.2%
4 Cm11c (R) ACh 474 237.0 6.1% 61.3%
5 Mi16 (R) GABA 459 229.5 5.9% 67.2%
6 MeVPMe13 (R) ACh 431 215.5 5.5% 72.8%
7 Tm5c (R) Glu 213 106.5 2.7% 75.5%
8 Cm29 (R) GABA 175 87.5 2.2% 77.8%
9 Cm-DRA (R) ACh 111 55.5 1.4% 79.2%
10 l-LNv (R) unclear 98 49.0 1.3% 80.4%
11 MeLo6 (R) ACh 90 45.0 1.2% 81.6%
12 Cm3 (R) GABA 86 43.0 1.1% 82.7%
13 Dm8a (R) Glu 62 31.0 0.8% 83.5%
14 Tm5a (R) ACh 45 22.5 0.6% 84.1%
15 Cm19 (R) GABA 42 21.0 0.5% 84.6%
16 Cm22 (R) GABA 39 19.5 0.5% 85.1%
17 MeVP2 (R) ACh 36 18.0 0.5% 85.6%
18 Cm1 (R) ACh 32 16.0 0.4% 86.0%
19 Cm21 (R) GABA 32 16.0 0.4% 86.4%
20 Cm7 (R) Glu 31 15.5 0.4% 86.8%
21 Cm8 (R) GABA 29 14.5 0.4% 87.2%
22 Tm40 (R) ACh 28 14.0 0.4% 87.5%
23 aMe4 (R) ACh 27 13.5 0.3% 87.9%
24 MeVP63 (R) GABA 27 13.5 0.3% 88.2%
25 MeVPMe13 (L) ACh 27 13.5 0.3% 88.6%
26 MeVP30 (R) ACh 26 13.0 0.3% 88.9%
27 Tm30 (R) GABA 25 12.5 0.3% 89.2%
28 MeLo1 (R) ACh 22 11.0 0.3% 89.5%
29 Lat2 (R) unclear 19 9.5 0.2% 89.8%
30 Cm2 (R) ACh 18 9.0 0.2% 90.0%
31 Cm31b (R) GABA 18 9.0 0.2% 90.2%
32 TmY18 (R) ACh 16 8.0 0.2% 90.4%
33 MeVC22 (R) Glu 15 7.5 0.2% 90.6%
34 TmY10 (R) ACh 15 7.5 0.2% 90.8%
35 Cm5 (R) GABA 14 7.0 0.2% 91.0%
36 MeVC21 (R) Glu 14 7.0 0.2% 91.2%
37 Tm5b (R) ACh 13 6.5 0.2% 91.3%
38 Cm10 (R) GABA 12 6.0 0.2% 91.5%
39 Cm31a (R) GABA 12 6.0 0.2% 91.6%
40 Li39 (L) GABA 12 6.0 0.2% 91.8%
41 aMe2 (R) Glu 11 5.5 0.1% 91.9%
42 aMe8 (R) ACh 11 5.5 0.1% 92.1%
43 Dm2 (R) ACh 11 5.5 0.1% 92.2%
44 aMe17c (R) Glu 10 5.0 0.1% 92.4%
45 Cm26 (R) Glu 10 5.0 0.1% 92.5%
46 Li20 (R) Glu 10 5.0 0.1% 92.6%
47 MeVP14 (R) ACh 10 5.0 0.1% 92.7%
48 MeVP15 (R) ACh 10 5.0 0.1% 92.9%
49 Mi15 (R) ACh 10 5.0 0.1% 93.0%
50 Tm5Y (R) ACh 10 5.0 0.1% 93.1%
51 5thsLNv_LNd6 (R) ACh 9 4.5 0.1% 93.2%
52 aMe17a (R) Glu 9 4.5 0.1% 93.4%
53 MeTu3c (R) ACh 9 4.5 0.1% 93.5%
54 MeVP10 (R) ACh 9 4.5 0.1% 93.6%
55 MeVP28 (R) ACh 9 4.5 0.1% 93.7%
56 aMe12 (R) ACh 8 4.0 0.1% 93.8%
57 Cm15 (R) GABA 8 4.0 0.1% 93.9%
58 MeLo3b (R) ACh 8 4.0 0.1% 94.0%
59 MeTu3b (R) ACh 8 4.0 0.1% 94.1%
60 MeVPLo2 (R) ACh 8 4.0 0.1% 94.2%
61 Tm33 (R) ACh 8 4.0 0.1% 94.3%
62 Dm9 (R) Glu 7 3.5 0.1% 94.4%
63 LoVP53 (R) ACh 7 3.5 0.1% 94.5%
64 LoVP96 (R) Glu 7 3.5 0.1% 94.6%
65 MeLo7 (R) ACh 7 3.5 0.1% 94.7%
66 Tm39 (R) ACh 7 3.5 0.1% 94.8%
67 aMe13 (R) unclear 6 3.0 0.1% 94.8%
68 aMe30 (R) Glu 6 3.0 0.1% 94.9%
69 Cm9 (R) Glu 6 3.0 0.1% 95.0%
70 Dm-DRA1 (R) Glu 6 3.0 0.1% 95.1%
71 LC11 (R) ACh 6 3.0 0.1% 95.2%
72 MeVC20 (R) Glu 6 3.0 0.1% 95.2%
73 MeVP47 (R) unclear 6 3.0 0.1% 95.3%
74 MeVP6 (R) Glu 6 3.0 0.1% 95.4%
75 MeVPMe2 (R) Glu 6 3.0 0.1% 95.5%
76 Tm36 (R) ACh 6 3.0 0.1% 95.5%
77 Cm28 (R) unclear 5 2.5 0.1% 95.6%
78 Dm-DRA2 (R) Glu 5 2.5 0.1% 95.7%
79 DN1a (R) unclear 5 2.5 0.1% 95.7%
80 DNp27 (R) unclear 5 2.5 0.1% 95.8%
81 Lat1 (R) unclear 5 2.5 0.1% 95.9%
82 MeVP9 (R) ACh 5 2.5 0.1% 95.9%
83 MeVPaMe1 (L) ACh 5 2.5 0.1% 96.0%
84 Tm3 (R) ACh 5 2.5 0.1% 96.1%
85 Tm31 (R) Glu 5 2.5 0.1% 96.1%
86 Tm37 (R) Glu 5 2.5 0.1% 96.2%
87 aMe17b (R) GABA 4 2.0 0.1% 96.2%
88 CL063 (R) unclear 4 2.0 0.1% 96.3%
89 Cm14 (R) GABA 4 2.0 0.1% 96.3%
90 Cm17 (R) GABA 4 2.0 0.1% 96.4%
91 Cm27 (R) Glu 4 2.0 0.1% 96.4%
92 Cm6 (R) GABA 4 2.0 0.1% 96.5%
93 Dm13 (R) GABA 4 2.0 0.1% 96.5%
94 L5 (R) ACh 4 2.0 0.1% 96.6%
95 Li22 (R) Glu 4 2.0 0.1% 96.6%
96 LoVC23 (L) GABA 4 2.0 0.1% 96.7%
97 LPLC1 (R) ACh 4 2.0 0.1% 96.7%
98 LT81 (R) unclear 4 2.0 0.1% 96.8%
99 MeTu1 (R) ACh 4 2.0 0.1% 96.9%
100 MeVP52 (R) ACh 4 2.0 0.1% 96.9%
101 Mi17 (R) GABA 4 2.0 0.1% 97.0%
102 Mi18 (R) GABA 4 2.0 0.1% 97.0%
103 Mi2 (R) Glu 4 2.0 0.1% 97.1%
104 Mi4 (R) GABA 4 2.0 0.1% 97.1%
105 PLP069 (R) unclear 4 2.0 0.1% 97.2%
106 PLP080 (R) unclear 4 2.0 0.1% 97.2%
107 aMe17e (R) Glu 3 1.5 0.0% 97.3%
108 aMe9 (R) ACh 3 1.5 0.0% 97.3%
109 C2 (R) GABA 3 1.5 0.0% 97.3%
110 Cm23 (R) Glu 3 1.5 0.0% 97.4%
111 LC10d (R) ACh 3 1.5 0.0% 97.4%
112 LC27 (R) ACh 3 1.5 0.0% 97.4%
113 MeLo2 (R) ACh 3 1.5 0.0% 97.5%
114 MeLo3a (R) ACh 3 1.5 0.0% 97.5%
115 MeLo4 (R) ACh 3 1.5 0.0% 97.6%
116 MeVP11 (R) ACh 3 1.5 0.0% 97.6%
117 MeVPLo2 (L) ACh 3 1.5 0.0% 97.6%
118 MeVPMe12 (R) ACh 3 1.5 0.0% 97.7%
119 MeVPMe3 (R) Glu 3 1.5 0.0% 97.7%
120 Mi1 (R) ACh 3 1.5 0.0% 97.8%
121 SLP249 (R) unclear 3 1.5 0.0% 97.8%
122 SLP250 (R) unclear 3 1.5 0.0% 97.8%
123 T2 (R) ACh 3 1.5 0.0% 97.9%
124 Tm29 (R) Glu 3 1.5 0.0% 97.9%
125 Tm6 (R) ACh 3 1.5 0.0% 97.9%
126 aMe23 (R) unclear 2 1.0 0.0% 98.0%
127 aMe24 (R) unclear 2 1.0 0.0% 98.0%
128 aMe5 (R) ACh 2 1.0 0.0% 98.0%
129 aMe_TBD1 (R) unclear 2 1.0 0.0% 98.0%
130 Cm12 (R) GABA 2 1.0 0.0% 98.1%
131 Cm18 (R) Glu 2 1.0 0.0% 98.1%
132 Cm30 (R) GABA 2 1.0 0.0% 98.1%
133 DNc01 (R) unclear 2 1.0 0.0% 98.1%
134 LC10a (R) ACh 2 1.0 0.0% 98.2%
135 LC10b (R) ACh 2 1.0 0.0% 98.2%
136 LC10c-2 (R) unclear 2 1.0 0.0% 98.2%
137 LC17 (R) unclear 2 1.0 0.0% 98.3%
138 LC21 (R) ACh 2 1.0 0.0% 98.3%
139 LC31a (R) ACh 2 1.0 0.0% 98.3%
140 LC9 (R) ACh 2 1.0 0.0% 98.3%
141 Li12 (R) Glu 2 1.0 0.0% 98.4%
142 Li14 (R) Glu 2 1.0 0.0% 98.4%
143 Li16 (R) Glu 2 1.0 0.0% 98.4%
144 Li18a (R) GABA 2 1.0 0.0% 98.4%
145 Li35 (R) GABA 2 1.0 0.0% 98.5%
146 LoVP12 (R) unclear 2 1.0 0.0% 98.5%
147 LoVP45 (R) Glu 2 1.0 0.0% 98.5%
148 MeLo11 (R) Glu 2 1.0 0.0% 98.5%
149 MeLo13 (R) Glu 2 1.0 0.0% 98.6%
150 MeTu4d (R) ACh 2 1.0 0.0% 98.6%
151 MeVC11 (L) ACh 2 1.0 0.0% 98.6%
152 MeVC23 (R) Glu 2 1.0 0.0% 98.6%
153 MeVC24 (R) Glu 2 1.0 0.0% 98.7%
154 MeVP12 (R) ACh 2 1.0 0.0% 98.7%
155 MeVP17 (R) Glu 2 1.0 0.0% 98.7%
156 MeVP27 (R) unclear 2 1.0 0.0% 98.7%
157 MeVP59 (R) ACh 2 1.0 0.0% 98.8%
158 MeVP7 (R) ACh 2 1.0 0.0% 98.8%
159 MeVPaMe2 (L) Glu 2 1.0 0.0% 98.8%
160 MeVPMe9 (L) Glu 2 1.0 0.0% 98.8%
161 T2a (R) ACh 2 1.0 0.0% 98.9%
162 Tm1 (R) ACh 2 1.0 0.0% 98.9%
163 Tm12 (R) ACh 2 1.0 0.0% 98.9%
164 Tm9 (R) ACh 2 1.0 0.0% 98.9%
165 TmY21 (R) ACh 2 1.0 0.0% 99.0%
166 TmY5a (R) Glu 2 1.0 0.0% 99.0%